| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FATE | FATE THERAPEUTICS INC | Dulac Edward J III | Chief Financial Officer | Mar 04, 2024 | Sale | $7.77 | 2,447 | 19,013 | 101,479 | Mar 05, 2024, 04:24 PM | |
| FATE | FATE THERAPEUTICS INC | Dulac Edward J III | Chief Financial Officer | Jan 29, 2024 | Sale | $5.00 | 1,849 | 9,245 | 103,926 | Jan 30, 2024, 04:01 PM | |
| FATE | FATE THERAPEUTICS INC | TAHL CINDY | General Counsel and Secretary | Jan 09, 2024 | Sale | $4.37 | 10,874 | 47,519 | 142,361 | Jan 10, 2024, 04:30 PM | |
| FATE | FATE THERAPEUTICS INC | Valamehr Bahram | Chief R&D Officer | Jan 09, 2024 | Sale | $4.38 | 11,271 | 49,367 | 158,069 | Jan 10, 2024, 04:30 PM | |
| FATE | FATE THERAPEUTICS INC | Wolchko J Scott | President and CEO | Jan 09, 2024 | Sale | $4.37 | 14,391 | 62,889 | 371,248 | Jan 10, 2024, 04:29 PM | |
| FATE | FATE THERAPEUTICS INC | Dulac Edward J III | Chief Financial Officer | Jan 09, 2024 | Sale | $4.37 | 7,028 | 30,712 | 105,775 | Jan 10, 2024, 04:29 PM | |
| FATE | FATE THERAPEUTICS INC | Dulac Edward J III | Chief Financial Officer | Jan 02, 2024 | Sale | $3.66 | 5,182 | 18,966 | 112,803 | Jan 03, 2024, 04:03 PM | |
| FATE | FATE THERAPEUTICS INC | Redmile Group, LLC | Director | Dec 26, 2023 | Buy | $3.72 | 3,355,370 | 12,481,976 | 13,180,388 | Dec 28, 2023, 09:30 PM | |
| FATE | FATE THERAPEUTICS INC | Dulac Edward J III | Chief Financial Officer | Dec 18, 2023 | Sale | $3.50 | 1,585 | 5,548 | 117,985 | Dec 19, 2023, 04:01 PM | |
| FATE | FATE THERAPEUTICS INC | TAHL CINDY | General Counsel and Secretary | Nov 09, 2023 | Sale | $2.40 | 24,363 | 58,471 | 153,235 | Nov 13, 2023, 04:01 PM | |
| FATE | FATE THERAPEUTICS INC | Dulac Edward J III | Chief Financial Officer | Aug 18, 2023 | Sale | $2.80 | 4,718 | 13,210 | 119,570 | Aug 21, 2023, 04:02 PM | |
| FATE | FATE THERAPEUTICS INC | Xu Yuan | Director | Aug 04, 2023 | Sale | $3.71 | 632 | 2,345 | 9,302 | Aug 07, 2023, 04:01 PM | |
| FATE | FATE THERAPEUTICS INC | Powl Brian T. | Chief Commercial Officer | Jul 05, 2023 | Sale | $4.87 | 3,854 | 18,769 | 41,146 | Jul 06, 2023, 05:19 PM | |
| FATE | FATE THERAPEUTICS INC | Dulac Edward J III | Chief Financial Officer | Jul 05, 2023 | Sale | $4.83 | 5,182 | 25,029 | 124,288 | Jul 06, 2023, 05:18 PM | |
| FATE | FATE THERAPEUTICS INC | Xu Yuan | Director | Jun 14, 2023 | Sale | $5.58 | 3,460 | 19,307 | 9,934 | Jun 15, 2023, 04:05 PM | |
| FATE | FATE THERAPEUTICS INC | Green Jeremy | Director | Apr 20, 2023 | Buy | $5.99 | 20,000 | 119,800 | 12,879,119 | Apr 21, 2023, 09:55 PM | |
| FATE | FATE THERAPEUTICS INC | Green Jeremy | Director | Apr 21, 2023 | Buy | $6.18 | 256,639 | 1,586,029 | 13,135,758 | Apr 21, 2023, 09:55 PM | |
| FATE | FATE THERAPEUTICS INC | Chu Yu-Waye | Chief Medical Officer | Apr 18, 2023 | Sale | $6.57 | 2,532 | 16,648 | 142,993 | Apr 19, 2023, 04:07 PM | |
| FATE | FATE THERAPEUTICS INC | Redmile Group, LLC | Director | Apr 14, 2023 | Buy | $5.84 | 11,312,809 | 66,070,918 | 12,859,119 | Apr 17, 2023, 09:30 PM | |
| FATE | FATE THERAPEUTICS INC | MENDLEIN JOHN | Director | Jan 19, 2023 | Option Exercise | $1.37 | 28,461 | 38,992 | 311,231 | Jan 20, 2023, 04:14 PM | |
| FATE | FATE THERAPEUTICS INC | MENDLEIN JOHN | Director | Jan 11, 2023 | Buy | $5.67 | 88,048 | 499,232 | 246,139 | Jan 13, 2023, 06:20 PM | |
| FATE | FATE THERAPEUTICS INC | MENDLEIN JOHN | Director | Jan 13, 2023 | Buy | $5.43 | 36,631 | 198,906 | 282,770 | Jan 13, 2023, 06:20 PM | |
| FATE | FATE THERAPEUTICS INC | Valamehr Bahram | Chief R&D Officer | Jan 12, 2023 | Option Exercise | $1.37 | 423 | 580 | 169,340 | Jan 13, 2023, 04:02 PM | |
| FATE | FATE THERAPEUTICS INC | Wolchko J Scott | President and CEO | Jan 10, 2023 | Sale | $5.24 | 45,907 | 240,553 | 385,639 | Jan 11, 2023, 04:09 PM | |
| FATE | FATE THERAPEUTICS INC | Valamehr Bahram | Chief R&D Officer | Jan 10, 2023 | Sale | $5.24 | 10,917 | 57,205 | 168,917 | Jan 11, 2023, 04:08 PM | |
| FATE | FATE THERAPEUTICS INC | TAHL CINDY | General Counsel and Secretary | Jan 10, 2023 | Sale | $5.24 | 11,553 | 60,538 | 177,598 | Jan 11, 2023, 04:08 PM | |
| FATE | FATE THERAPEUTICS INC | Plavsic Mark | Chief Technical Officer | Jan 10, 2023 | Sale | $5.24 | 3,418 | 17,910 | 123,705 | Jan 11, 2023, 04:07 PM | |
| FATE | FATE THERAPEUTICS INC | Dulac Edward J III | Chief Financial Officer | Jan 10, 2023 | Sale | $5.24 | 7,331 | 38,414 | 129,470 | Jan 11, 2023, 04:06 PM | |
| FATE | FATE THERAPEUTICS INC | Chu Yu-Waye | Chief Medical Officer | Jan 10, 2023 | Sale | $5.24 | 7,825 | 41,003 | 143,208 | Jan 11, 2023, 04:05 PM | |
| FATE | FATE THERAPEUTICS INC | Dulac Edward J III | Chief Financial Officer | Aug 18, 2022 | Sale | $29.81 | 5,135 | 153,051 | 137,233 | Aug 19, 2022, 06:58 PM | |
| FATE | FATE THERAPEUTICS INC | Wolchko J Scott | President and CEO | Jul 22, 2022 | Sale | $17.39 | 12,492 | 217,220 | 437,792 | Jul 25, 2022, 06:18 PM | |
| FATE | FATE THERAPEUTICS INC | Wolchko J Scott | President and CEO | Jul 21, 2022 | Sale | $17.79 | 60,000 | 1,067,361 | 461,546 | Jul 25, 2022, 06:18 PM | |
| FATE | FATE THERAPEUTICS INC | Valamehr Bahram | Chief R&D Officer | Jul 07, 2022 | Option Exercise | $16.48 | 34,316 | 565,528 | 196,992 | Jul 08, 2022, 04:51 PM | |
| FATE | FATE THERAPEUTICS INC | Valamehr Bahram | Chief R&D Officer | Jul 06, 2022 | Option Exercise | $16.67 | 15,684 | 261,438 | 187,676 | Jul 07, 2022, 04:04 PM | |
| FATE | FATE THERAPEUTICS INC | Agarwal Shefali | Director | Jun 07, 2022 | Sale | $21.89 | 841 | 18,409 | 1,840 | Jun 08, 2022, 04:03 PM | |
| FATE | FATE THERAPEUTICS INC | MENDLEIN JOHN | Director | Jun 03, 2022 | Sale | $22.79 | 1,364 | 31,086 | 158,091 | Jun 06, 2022, 04:49 PM | |
| FATE | FATE THERAPEUTICS INC | Jooss Karin | Director | Jun 03, 2022 | Sale | $22.82 | 1,483 | 33,842 | 1,198 | Jun 06, 2022, 04:48 PM | |
| FATE | FATE THERAPEUTICS INC | HERSHBERG ROBERT | Director | Jun 03, 2022 | Sale | $22.75 | 672 | 15,288 | 2,009 | Jun 06, 2022, 04:45 PM | |
| FATE | FATE THERAPEUTICS INC | COUGHLIN TIMOTHY | Director | Jun 03, 2022 | Sale | $22.81 | 1,439 | 32,824 | 57,632 | Jun 06, 2022, 04:43 PM | |
| FATE | FATE THERAPEUTICS INC | Agarwal Shefali | Director | Jun 03, 2022 | Sale | $22.80 | 807 | 18,400 | 1,874 | Jun 06, 2022, 04:40 PM | |
| FATE | FATE THERAPEUTICS INC | TAHL CINDY | General Counsel and Secretary | Jun 01, 2022 | Option Exercise | $14.75 | 50,000 | 737,750 | 214,151 | Jun 02, 2022, 04:04 PM | |
| FATE | FATE THERAPEUTICS INC | Wolchko J Scott | President and CEO | Apr 21, 2022 | Sale | $18.85 | 60,000 | 1,130,881 | 461,546 | Apr 25, 2022, 04:11 PM | |
| FATE | FATE THERAPEUTICS INC | Wolchko J Scott | President and CEO | Apr 22, 2022 | Sale | $18.65 | 20,000 | 372,911 | 441,546 | Apr 25, 2022, 04:11 PM | |
| FATE | FATE THERAPEUTICS INC | Chu Yu-Waye | Chief Medical Officer | Apr 19, 2022 | Sale | $35.37 | 4,062 | 143,673 | 151,033 | Apr 21, 2022, 04:04 PM | |
| FATE | FATE THERAPEUTICS INC | Valamehr Bahram | Chief R&D Officer | Mar 14, 2022 | Sale | $16.90 | 50,000 | 844,983 | 204,834 | Mar 15, 2022, 04:27 PM | |
| FATE | FATE THERAPEUTICS INC | MENDLEIN JOHN | Director | Mar 10, 2022 | Sale | $18.32 | 63,124 | 1,156,646 | 191,017 | Mar 11, 2022, 04:58 PM | |
| FATE | FATE THERAPEUTICS INC | Wolchko J Scott | President and CEO | Jan 20, 2022 | Option Exercise | $2.70 | 30,000 | 81,000 | 461,546 | Feb 04, 2022, 05:59 PM | |
| FATE | FATE THERAPEUTICS INC | Wolchko J Scott | President and CEO | Jan 20, 2022 | Option Exercise | $21.47 | 60,000 | 1,288,200 | 461,546 | Jan 24, 2022, 04:36 PM | |
| FATE | FATE THERAPEUTICS INC | Wolchko J Scott | President and CEO | Jan 21, 2022 | Option Exercise | $20.36 | 20,000 | 407,200 | 441,546 | Jan 24, 2022, 04:36 PM | |
| FATE | FATE THERAPEUTICS INC | Wolchko J Scott | President and CEO | Jan 11, 2022 | Sale | $48.68 | 14,566 | 709,027 | 436,065 | Jan 13, 2022, 04:09 PM | |
| FATE | FATE THERAPEUTICS INC | TAHL CINDY | General Counsel and Secretary | Jan 11, 2022 | Sale | $48.53 | 5,419 | 262,975 | 156,385 | Jan 13, 2022, 04:08 PM | |
| FATE | FATE THERAPEUTICS INC | Valamehr Bahram | Chief R&D Officer | Jan 11, 2022 | Sale | $48.50 | 4,570 | 221,655 | 146,950 | Jan 13, 2022, 04:07 PM | |
| FATE | FATE THERAPEUTICS INC | Dulac Edward J III | Chief Financial Officer | Jan 11, 2022 | Sale | $48.45 | 1,770 | 85,757 | 109,024 | Jan 13, 2022, 04:06 PM | |
| FATE | FATE THERAPEUTICS INC | Chu Yu-Waye | Senior VP Clinical Development | Jan 11, 2022 | Sale | $48.51 | 3,965 | 192,340 | 122,211 | Jan 13, 2022, 04:05 PM | |
| FATE | FATE THERAPEUTICS INC | Wolchko J Scott | President and CEO | Jan 10, 2022 | Sale | $46.86 | 34,156 | 1,600,534 | 467,107 | Jan 12, 2022, 04:07 PM | |
| FATE | FATE THERAPEUTICS INC | TAHL CINDY | General Counsel and Secretary | Jan 10, 2022 | Sale | $46.43 | 7,738 | 359,313 | 161,911 | Jan 12, 2022, 04:06 PM | |
| FATE | FATE THERAPEUTICS INC | Valamehr Bahram | Chief R&D Officer | Jan 10, 2022 | Sale | $46.38 | 5,596 | 259,558 | 151,453 | Jan 12, 2022, 04:05 PM | |
| FATE | FATE THERAPEUTICS INC | TAHL CINDY | General Counsel and Secretary | Jan 03, 2022 | Option Exercise | $32.94 | 100,000 | 3,294,353 | 219,006 | Jan 04, 2022, 04:03 PM | |
| FATE | FATE THERAPEUTICS INC | Dulac Edward J III | Chief Financial Officer | Dec 20, 2021 | Option Exercise | $48.38 | 30,414 | 1,471,422 | 126,381 | Dec 21, 2021, 04:08 PM | |
| FATE | FATE THERAPEUTICS INC | Valamehr Bahram | Chief R&D Officer | Dec 13, 2021 | Sale | $25.19 | 50,000 | 1,259,656 | 181,698 | Dec 14, 2021, 04:18 PM | |
| FATE | FATE THERAPEUTICS INC | Chu Yu-Waye | Senior VP Clinical Development | Dec 10, 2021 | Sale | $33.89 | 15,000 | 508,348 | 133,258 | Dec 13, 2021, 05:53 PM | |
| FATE | FATE THERAPEUTICS INC | Wolchko J Scott | President and CEO | Nov 18, 2021 | Option Exercise | $28.49 | 40,000 | 1,139,400 | 413,793 | Nov 22, 2021, 05:45 PM | |
| FATE | FATE THERAPEUTICS INC | Wolchko J Scott | President and CEO | Oct 21, 2021 | Sale | $31.47 | 60,000 | 1,888,460 | 423,793 | Oct 25, 2021, 04:04 PM | |
| FATE | FATE THERAPEUTICS INC | Wolchko J Scott | President and CEO | Oct 22, 2021 | Option Exercise | $30.97 | 60,000 | 1,858,070 | 423,793 | Oct 25, 2021, 04:04 PM | |
| FATE | FATE THERAPEUTICS INC | TAHL CINDY | General Counsel and Secretary | Oct 01, 2021 | Sale | $32.69 | 100,000 | 3,268,962 | 158,048 | Oct 04, 2021, 04:12 PM | |
| FATE | FATE THERAPEUTICS INC | Dulac Edward J III | Chief Financial Officer | Sep 28, 2021 | Option Exercise | $49.81 | 36,785 | 1,832,218 | 71,864 | Sep 30, 2021, 04:14 PM | |
| FATE | FATE THERAPEUTICS INC | Valamehr Bahram | Chief Development Officer | Sep 13, 2021 | Sale | $34.51 | 50,000 | 1,725,507 | 120,740 | Sep 14, 2021, 04:01 PM | |
| FATE | FATE THERAPEUTICS INC | Wolchko J Scott | President and CEO | Aug 19, 2021 | Option Exercise | $46.42 | 40,000 | 1,856,904 | 413,793 | Aug 20, 2021, 04:02 PM | |
| FATE | FATE THERAPEUTICS INC | Dulac Edward J III | Chief Financial Officer | Aug 19, 2021 | Sale | $88.26 | 3,474 | 306,602 | 56,076 | Aug 20, 2021, 04:01 PM | |
| FATE | FATE THERAPEUTICS INC | Wolchko J Scott | President and CEO | Jul 22, 2021 | Sale | $44.39 | 60,000 | 2,663,475 | 423,793 | Jul 26, 2021, 04:05 PM | |
| FATE | FATE THERAPEUTICS INC | Wolchko J Scott | President and CEO | Jul 23, 2021 | Option Exercise | $44.71 | 60,000 | 2,682,638 | 423,793 | Jul 26, 2021, 04:05 PM | |
| FATE | FATE THERAPEUTICS INC | TAHL CINDY | General Counsel and Secretary | Jul 01, 2021 | Sale | $45.44 | 111,068 | 5,046,985 | 163,582 | Jul 02, 2021, 07:08 PM | |
| FATE | FATE THERAPEUTICS INC | Chu Yu-Waye | Senior VP Clinical Development | Apr 16, 2021 | Sale | $83.30 | 3,275 | 272,809 | 67,200 | Apr 20, 2021, 04:00 PM | |
| FATE | FATE THERAPEUTICS INC | TAHL CINDY | See Remarks | Apr 01, 2021 | Sale | $43.51 | 60,000 | 2,610,529 | 138,048 | Apr 02, 2021, 06:03 PM | |
| FATE | FATE THERAPEUTICS INC | Valamehr Bahram | Chief Development Officer | Mar 15, 2021 | Sale | $47.63 | 50,000 | 2,381,272 | 120,740 | Mar 16, 2021, 04:05 PM | |
| FATE | FATE THERAPEUTICS INC | Shoemaker Daniel D | Chief Scientific Officer | Mar 08, 2021 | Sale | $81.74 | 25,000 | 2,043,428 | 94,722 | Mar 09, 2021, 04:02 PM | |
| FATE | FATE THERAPEUTICS INC | Wolchko J Scott | President and CEO | Feb 18, 2021 | Sale | $54.32 | 40,000 | 2,172,656 | 413,793 | Feb 19, 2021, 04:07 PM | |
| FATE | FATE THERAPEUTICS INC | Wolchko J Scott | President and CEO | Jan 22, 2021 | Sale | $51.81 | 60,000 | 3,108,313 | 423,793 | Jan 22, 2021, 06:23 PM | |
| FATE | FATE THERAPEUTICS INC | Wolchko J Scott | President and CEO | Jan 21, 2021 | Sale | $52.89 | 60,000 | 3,173,261 | 423,793 | Jan 22, 2021, 06:23 PM | |
| FATE | FATE THERAPEUTICS INC | TAHL CINDY | General Counsel and Secretary | Jan 19, 2021 | Sale | $58.83 | 70,000 | 4,118,143 | 125,035 | Jan 21, 2021, 07:08 PM | |
| FATE | FATE THERAPEUTICS INC | Wolchko J Scott | President and CEO | Jan 08, 2021 | Sale | $117.10 | 60,820 | 7,122,217 | 393,065 | Jan 12, 2021, 08:41 PM | |
| FATE | FATE THERAPEUTICS INC | Wolchko J Scott | President and CEO | Jan 11, 2021 | Sale | $110.81 | 8,587 | 951,556 | 355,634 | Jan 12, 2021, 08:41 PM | |
| FATE | FATE THERAPEUTICS INC | Valamehr Bahram | Chief Development Officer | Jan 08, 2021 | Sale | $117.10 | 6,230 | 729,552 | 84,455 | Jan 12, 2021, 08:40 PM | |
| FATE | FATE THERAPEUTICS INC | Valamehr Bahram | Chief Development Officer | Jan 11, 2021 | Sale | $110.81 | 3,254 | 360,588 | 79,649 | Jan 12, 2021, 08:40 PM | |
| FATE | FATE THERAPEUTICS INC | TAHL CINDY | General Counsel and Secretary | Jan 08, 2021 | Sale | $117.10 | 6,229 | 729,434 | 96,763 | Jan 12, 2021, 08:39 PM | |
| FATE | FATE THERAPEUTICS INC | TAHL CINDY | General Counsel and Secretary | Jan 11, 2021 | Sale | $110.81 | 3,254 | 360,587 | 91,957 | Jan 12, 2021, 08:39 PM | |
| FATE | FATE THERAPEUTICS INC | Shoemaker Daniel D | Chief Scientific Officer | Jan 08, 2021 | Sale | $117.10 | 6,229 | 729,434 | 90,336 | Jan 12, 2021, 08:38 PM | |
| FATE | FATE THERAPEUTICS INC | Shoemaker Daniel D | Chief Scientific Officer | Jan 11, 2021 | Sale | $110.81 | 3,253 | 360,477 | 85,530 | Jan 12, 2021, 08:38 PM | |
| FATE | FATE THERAPEUTICS INC | Green Jeremy | Director | Jan 08, 2021 | Buy | $85.50 | 327,485 | 27,999,968 | 12,957,222 | Jan 12, 2021, 04:16 PM | |
| FATE | FATE THERAPEUTICS INC | Wolchko J Scott | President and CEO | Dec 17, 2020 | Option Exercise | $49.22 | 40,000 | 1,968,752 | 439,969 | Dec 18, 2020, 04:01 PM | |
| FATE | FATE THERAPEUTICS INC | Valamehr Bahram | Chief Development Officer | Dec 14, 2020 | Sale | $50.34 | 50,000 | 2,516,977 | 112,211 | Dec 15, 2020, 04:01 PM | |
| FATE | FATE THERAPEUTICS INC | Shoemaker Daniel D | Chief Scientific Officer | Nov 16, 2020 | Sale | $51.83 | 25,000 | 1,295,746 | 113,159 | Nov 16, 2020, 05:12 PM | |
| FATE | FATE THERAPEUTICS INC | Wolchko J Scott | President and CEO | Nov 12, 2020 | Sale | $27.72 | 60,000 | 1,663,424 | 449,969 | Nov 16, 2020, 04:02 PM | |
| FATE | FATE THERAPEUTICS INC | Wolchko J Scott | President and CEO | Nov 13, 2020 | Sale | $28.38 | 60,000 | 1,702,907 | 430,123 | Nov 16, 2020, 04:02 PM | |
| FATE | FATE THERAPEUTICS INC | TAHL CINDY | General Counsel and Secretary | Nov 04, 2020 | Sale | $26.57 | 103,038 | 2,737,787 | 151,037 | Nov 06, 2020, 04:02 PM | |
| FATE | FATE THERAPEUTICS INC | TAHL CINDY | General Counsel and Secretary | Nov 05, 2020 | Option Exercise | $26.72 | 38,564 | 1,030,592 | 118,800 | Nov 06, 2020, 04:02 PM | |
| FATE | FATE THERAPEUTICS INC | TAHL CINDY | General Counsel and Secretary | Oct 16, 2020 | Sale | $26.49 | 58,398 | 1,546,925 | 128,717 | Oct 20, 2020, 04:01 PM | |
| FATE | FATE THERAPEUTICS INC | TAHL CINDY | General Counsel and Secretary | Oct 01, 2020 | Sale | $21.74 | 70,000 | 1,521,615 | 134,518 | Oct 02, 2020, 12:00 AM | |
| FATE | FATE THERAPEUTICS INC | Valamehr Bahram | Chief Development Officer | Sep 14, 2020 | Option Exercise | $19.52 | 50,000 | 975,802 | 112,211 | Sep 16, 2020, 04:02 PM | |
| FATE | FATE THERAPEUTICS INC | Shoemaker Daniel D | Chief Scientific Officer | Sep 14, 2020 | Sale | $36.30 | 25,000 | 907,540 | 141,691 | Sep 16, 2020, 04:01 PM |
Menu